Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes.

PURPOSE To examine the association of retinal vessel tortuosity with diabetic retinopathy and early nephropathy in type 1 diabetes. DESIGN Cross-sectional. METHODS A total of 1159 participants with type 1 diabetes aged 12 to 20 years, attending diabetes clinics in Children's Hospital at Westmead, Sydney, Australia between 1990 and 2002, were included. Retinal photography and clinical examinations were performed during the baseline visit to assess diabetic retinopathy and albumin excretion rate (AER). Retinal vessel tortuosity was measured from digitized retinal photographs using a semi-automated computer program by a single grader masked to participants' characteristics. Diabetic retinopathy was defined as ETDRS level ≥21 (mild nonproliferative retinopathy) and early kidney dysfunction was defined as AER ≥7.5 μg/min. RESULTS Of 944 patients (81.4%), 85 (9.0%) had signs of retinopathy only, 250 (26.5%) had early kidney dysfunction only, and 85 (9.0%) had both retinopathy and early kidney dysfunction. In multivariate analysis, higher arteriolar tortuosity was associated with retinopathy (odds ratio [OR] 2.01, 95% confidence interval [CI] 1.23-3.29, the highest quartile vs the remaining 3 quartiles), early kidney dysfunction (OR 1.56, 95% CI 1.06-2.28, per standard deviation [SD] increase), or coexistence of both complications (OR 1.96, 95% CI 1.21-3.24, the highest quartile vs the remaining 3 quartiles). CONCLUSIONS Greater retinal arteriolar tortuosity was independently associated with retinopathy and early stage of nephropathy in type 1 diabetes. These findings may offer the potential of quantitative measurement of retinal vessel tortuosity for diabetic complication risk assessment.

[1]  B. Petrig,et al.  Diabetic Glycemic Control and Retinal Blood Flow , 1990, Diabetes.

[2]  I. Hirsch,et al.  Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. , 2010, JAMA.

[3]  J. Sundberg,et al.  Role of COL4A1 in small-vessel disease and hemorrhagic stroke. , 2006, The New England journal of medicine.

[4]  N. Laver,et al.  Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. , 1995, Investigative ophthalmology & visual science.

[5]  A. Gotlieb,et al.  Partial Off-Loading of Longitudinal Tension Induces Arterial Tortuosity , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Grace Byfield,et al.  Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. , 2008, Investigative ophthalmology & visual science.

[7]  E M Kohner,et al.  Role of Blood Flow and Impaired Autoregulation in the Pathogenesis of Diabetic Retinopathy , 1995, Diabetes.

[8]  H. Hammes.  Pericytes and the pathogenesis of diabetic retinopathy. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  Tien Yin Wong,et al.  Retinal Arteriolar Dilation Predicts Retinopathy in Adolescents With Type 1 Diabetes , 2008, Diabetes Care.

[10]  Michael H. Goldbaum,et al.  Measurement and classification of retinal vascular tortuosity , 1999, Int. J. Medical Informatics.

[11]  A. Yoshida,et al.  Retinal blood flow changes in type I diabetes. A long-term follow-up study. , 1996, Investigative ophthalmology & visual science.

[12]  T. Wong,et al.  Retinal Vascular Changes in Pre-Diabetes and Prehypertension , 2007, Diabetes Care.

[13]  T. Lehtimäki,et al.  Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes , 2004, Circulation.

[14]  A. Hofman,et al.  Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. , 2006, Diabetes.

[15]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[16]  Richard F Spaide,et al.  Early bevacizumab treatment of central retinal vein occlusion. , 2007, American journal of ophthalmology.

[17]  Paul Mitchell,et al.  Retinal Arteriolar Narrowing Predicts Incidence of Diabetes , 2008, Diabetes.

[18]  Wynne Hsu,et al.  Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes , 2010, Diabetes Care.

[19]  M. Cooper,et al.  Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. , 1999, Diabetes.

[20]  A E Leure-duPree,et al.  Electron-opaque inclusions in the rat retinal pigment epithelium after treatment with chelators of zinc. , 1981, Investigative ophthalmology & visual science.

[21]  D. Celermajer,et al.  Large Vessel Dysfunction in Diabetic Adolescents and its Relationship to Small Vessel Complications , 1997, Journal of pediatric endocrinology & metabolism : JPEM.

[22]  Michael H. Goldbaum,et al.  Automated measurement of retinal vascular tortuosity , 1997, AMIA.

[23]  Tien Yin Wong,et al.  Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. , 2004, Diabetes.

[24]  Edwin A M Gale.  The rise of childhood type 1 diabetes in the 20th century. , 2002, Diabetes.

[25]  M. Larsen,et al.  Straight versus tortuous retinal arteries in relation to blood pressure and genetics , 2008, British Journal of Ophthalmology.

[26]  H. Hammes,et al.  Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. , 1998, Diabetes.

[27]  Nish Chaturvedi,et al.  Impact of Size at Birth on the Microvasculature: The Avon Longitudinal Study of Parents and Children , 2007, Pediatrics.

[28]  R. Klein,et al.  Abnormalities of Retinal Microvascular Structure and Risk of Mortality From Ischemic Heart Disease and Stroke , 2006, Hypertension.

[29]  C E Riva,et al.  Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. , 1992, Investigative ophthalmology & visual science.

[30]  T. Curtis,et al.  Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? , 2009, Eye.

[31]  Tien Yin Wong,et al.  Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. , 2010, Ophthalmology.

[32]  P. Dobrin,et al.  Mechanisms of arterial and aneurysmal tortuosity. , 1988, Surgery.

[33]  M. Atkinson,et al.  The Juvenile Diabetes Research Foundation at Forty: Updates of Research in Type 1 Diabetes , 2010, Diabetes.

[34]  J. Tuomilehto,et al.  Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999 , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[35]  M. Craig,et al.  Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. , 2005, Diabetes care.

[36]  R. Kawasaki,et al.  Retinal vessel calibre and micro- and macrovascular complications in type 1 diabetes , 2009, Diabetologia.

[37]  T. Wierzbicki,et al.  The relationship between retinal vessel tortuosity, diameter, and transmural pressure , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[38]  A. Yoshida,et al.  Retinal Blood Flow Changes in Type I Diabetes , 1996 .

[39]  Zheen Zhao,et al.  Computer-assisted measurement of retinal vascular width and tortuosity in retinopathy of prematurity. , 2010, Archives of ophthalmology.

[40]  J. Sahel,et al.  Decreased venous tortuosity associated with resolution of macular edema after intravitreal injection of triamcinolone. , 2005, Retina.

[41]  Einar Stefánsson,et al.  Retinal vessel dilatation and elongation precedes diabetic macular oedema , 1997, The British journal of ophthalmology.

[42]  Denis Daneman,et al.  Type 1 diabetes , 2018, The Lancet.